Jochen Casper

Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantation

Richard F. Schlenk, Sabine Käyser, Lars Bullinger et al. · Blood · 2014 · 400 citations · Full text

Life Sciences, Genetics, Molecular Genetics +3

CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients

Laurent Arnaud, B. Hervier, A. Néel et al. · Blood · 2011 · 384 citations · Full text

Pharmacy, Neurology, Neuroimmunology +4

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial

Dietrich W. Beelen, Rudolf Trenschel, Matthias Stelljes et al. · The Lancet Haematology · 2019 · 154 citations · Full text

Medicine, Hematology, Immunology +17

Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation

Jochen Casper, Wolfgang Knauf, Thomas Kiefer et al. · Blood · 2003 · 146 citations · Full text

Medicine, Hematology, Oncology +13

Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumours

Peter W. Andrews, Jochen Casper, Ivan Damjanov et al. · International Journal of Cancer · 1996 · 112 citations · Full text

Life Sciences, Cell Biology, Oncology +17